Xiugui Sheng

1.9k total citations
74 papers, 1.4k citations indexed

About

Xiugui Sheng is a scholar working on Obstetrics and Gynecology, Molecular Biology and Surgery. According to data from OpenAlex, Xiugui Sheng has authored 74 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Obstetrics and Gynecology, 22 papers in Molecular Biology and 18 papers in Surgery. Recurrent topics in Xiugui Sheng's work include Endometrial and Cervical Cancer Treatments (29 papers), Ovarian cancer diagnosis and treatment (14 papers) and Cervical Cancer and HPV Research (9 papers). Xiugui Sheng is often cited by papers focused on Endometrial and Cervical Cancer Treatments (29 papers), Ovarian cancer diagnosis and treatment (14 papers) and Cervical Cancer and HPV Research (9 papers). Xiugui Sheng collaborates with scholars based in China, United States and United Kingdom. Xiugui Sheng's co-authors include Hui Guo, Naifu Liu, Chunxiao Zhou, Qingshui Li, Victoria Bae‐Jump, Xuelian Du, Jianjun Han, Adam K. Willson, Wenli Xie and Hao Yu and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Pharmaceutics.

In The Last Decade

Xiugui Sheng

68 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiugui Sheng China 23 513 393 344 304 233 74 1.4k
Xingsheng Yang China 27 800 1.6× 325 0.8× 412 1.2× 409 1.3× 334 1.4× 95 1.8k
Haoran Li China 14 491 1.0× 161 0.4× 345 1.0× 336 1.1× 91 0.4× 81 1.1k
Thomas Schöndorf Germany 21 590 1.2× 215 0.5× 145 0.4× 341 1.1× 110 0.5× 71 1.4k
Bert Delvoux Netherlands 22 489 1.0× 335 0.9× 110 0.3× 185 0.6× 480 2.1× 53 1.5k
Étienne Buscail France 18 336 0.7× 105 0.3× 304 0.9× 651 2.1× 164 0.7× 55 1.3k
Lara J. Monteiro Chile 19 1.3k 2.5× 234 0.6× 449 1.3× 315 1.0× 48 0.2× 36 1.8k
Nilgün Kapucuoğlu Türkiye 20 253 0.5× 96 0.2× 187 0.5× 304 1.0× 94 0.4× 74 1000
Wiesława Niklińska Poland 23 577 1.1× 72 0.2× 271 0.8× 393 1.3× 78 0.3× 77 1.3k

Countries citing papers authored by Xiugui Sheng

Since Specialization
Citations

This map shows the geographic impact of Xiugui Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiugui Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiugui Sheng more than expected).

Fields of papers citing papers by Xiugui Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiugui Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiugui Sheng. The network helps show where Xiugui Sheng may publish in the future.

Co-authorship network of co-authors of Xiugui Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiugui Sheng. A scholar is included among the top collaborators of Xiugui Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiugui Sheng. Xiugui Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Hui, et al.. (2023). Prognostic Value of Body Composition and Systemic Inflammatory Markers in Patients with Locally Advanced Cervical Cancer Following Chemoradiotherapy. Journal of Inflammation Research. Volume 16. 5145–5156. 9 indexed citations
2.
Peng, Fang, et al.. (2023). Role of GPX4 inhibition-mediated ferroptosis in the chemoresistance of ovarian cancer to Taxol in vitro. Molecular Biology Reports. 50(12). 10189–10198. 4 indexed citations
4.
Uyar, Denise, Li-Shu Wang, David G. Mutch, et al.. (2019). SOX11 hypermethylation as a tumor biomarker in endometrial cancer. Biochimie. 162. 8–14. 15 indexed citations
5.
Guo, Hui, et al.. (2018). The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention. Journal of Ovarian Research. 11(1). 71–71. 37 indexed citations
6.
Wang, Xiangyu, Jim Jinn‐Chyuan Sheu, Ming-Tsung Lai, et al.. (2018). RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer. Biomedicine. 8(1). 4–4. 41 indexed citations
7.
Yu, Hao, Linlin Zhang, Xuelian Du, & Xiugui Sheng. (2016). Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy in early-stage cervical cancer patients with intermediate risk factors. OncoTargets and Therapy. Volume 9. 7331–7335. 7 indexed citations
8.
Li, Huiqin, et al.. (2015). The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy. International Journal of Gynecological Cancer. 25(6). 1058–1065. 12 indexed citations
9.
Zhang, Ying, Jing Guo, Xiaoling Zhang, et al.. (2015). Antibody fragment-armed mesoporous silica nanoparticles for the targeted delivery of bevacizumab in ovarian cancer cells. International Journal of Pharmaceutics. 496(2). 1026–1033. 42 indexed citations
10.
Zhang, Ying, et al.. (2015). Prognostic factors and genes associated with endometrial cancer based on gene expression profiling by bioinformatics analysis. Archives of Gynecology and Obstetrics. 293(6). 1287–1295. 14 indexed citations
11.
Liu, Ting, Xuelian Du, & Xiugui Sheng. (2014). Genetic alterations following ionizing radiation in human ovarian cancer-derived endothelial cells. Molecular Medicine Reports. 9(6). 2257–2264. 2 indexed citations
12.
Jiang, Si‐Tse, et al.. (2014). Metastasis of a cervical carcinoma to the clitoris. Journal of Obstetrics and Gynaecology. 35(2). 213–214. 3 indexed citations
13.
Zhang, Lu, Jianjun Han, Xiaohong Liang, et al.. (2014). The Association of HMGB1 Expression with Clinicopathological Significance and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis and Literature Review. PLoS ONE. 9(10). e110626–e110626. 30 indexed citations
14.
Wu, Fengxia, et al.. (2013). TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88-positive human ovarian carcinoma in vitro. Oncology Letters. 7(3). 871–877. 47 indexed citations
15.
Du, Xuelian, Tao Jiang, Xiugui Sheng, et al.. (2011). Intensity-modulated radiation therapy for advanced cervical cancer: A comparison of dosimetric and clinical outcomes with conventional radiotherapy. Gynecologic Oncology. 125(1). 151–157. 61 indexed citations
16.
Liu, Naifu, Xingwu Wang, & Xiugui Sheng. (2010). The clinicopathological characteristics of ‘triple-negative’ epithelial ovarian cancer. Journal of Clinical Pathology. 63(3). 240–243. 16 indexed citations
17.
Gao, Rong, Naifu Liu, & Xiugui Sheng. (2010). Malignant ovarian melanoma with extensive pelvic and peritoneal metastasis: a case report and literature review. Chinese Journal of Cancer. 29(4). 460–462. 8 indexed citations
18.
Liu, Naifu, Xingwu Wang, & Xiugui Sheng. (2010). ‘Triple negative’ epithelial ovarian cancer and pathologic markers for prognosis. Current Opinion in Obstetrics & Gynecology. 23(1). 19–23. 5 indexed citations
20.
Wang, Fengwei, Ke Liang, Weibo Yin, Yu Shen, & Xiugui Sheng. (1999). Radiation-induced apoptosis of two nasopharangeal carcinoma cell lines. Chinese Journal of Cancer Research. 11(1). 35–37. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026